Aerovate Therapeutics, Inc. (AVTE): Price and Financial Metrics
AVTE Price/Volume Stats
| Current price | $2.58 | 52-week high | $32.42 |
| Prev. close | $2.43 | 52-week low | $1.25 |
| Day low | $2.44 | Volume | 249,800 |
| Day high | $2.60 | Avg. volume | 298,409 |
| 50-day MA | $2.61 | Dividend yield | N/A |
| 200-day MA | $7.19 | Market Cap | 74.50M |
AVTE Stock Price Chart Interactive Chart >
Aerovate Therapeutics, Inc. (AVTE) Company Bio
Aerovate Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs that enhance the lives of patients with rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.
AVTE Price Returns
| 1-mo | 1.98% |
| 3-mo | 17.27% |
| 6-mo | 34.38% |
| 1-year | -87.10% |
| 3-year | -68.73% |
| 5-year | N/A |
| YTD | -2.64% |
| 2024 | -88.29% |
| 2023 | -22.76% |
| 2022 | 148.52% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...